MarketMoodz
Analysts Load Up on Nvidia, Micron, Ferrari and Rocket Lab
A wave of analyst upgrades and fresh coverage landed Monday, targeting AI/semi names like Nvidia and Micron alongside industrial and aerospace plays including Ferrari and Rocket Lab. Traders should expect near-term market ripples as price-target raises and rating changes sharpen positioning ahead of key earnings and potential catalysts.
Key Takeaways
- TD Cowen reportedly raised Micron’s price target to $1,500 and penciled in $23 EPS for MayQ and $27 for AugQ.
- Melius reiterated Nvidia as a Buy, highlighting AI, semiconductors and the rise of ‘digital workers’ and physical AI demand.
- Morgan Stanley upgraded Ferrari (RACE) to Overweight and raised its price target to $438 from $388.
- KeyBanc upgraded Rocket Lab (RKLB) and Firefly Aerospace (FLY) to Overweight, citing SpaceX IPO dynamics and a decade-long supply-demand gap in launch capacity.
- The slate included multiple fresh Buy/Overweight initiations across small caps (JADE, CEVA, ESCO, WULF, ICUI, TWST, BKD) and notable moves like Baird’s downgrade of Roku to Neutral.
People Involved
- No specific individuals mentioned
Entities Involved
- Nvidia (NVDA)AI/semiconductor leader highlighted by Melius as Buy
- Micron Technology (MU)Memory chipmaker with a reported $1,500 price target from TD Cowen and EPS forecasts
- Ferrari N.V. (RACE)Upgraded to Overweight by Morgan Stanley with a raised price target
- Rocket Lab USA (RKLB)Upgraded to Overweight by KeyBanc amid launch supply-demand commentary
- DataDog (DDOG)Mentioned in the headline; no additional detail in excerpt
- Onto Innovation (ONTO)Upgraded to Overweight by Morgan Stanley
- Esco Technologies (ESCO)Initiated Overweight by JPMorgan with a Dec-2027 price target of $420
- 3M Company (MMM)Reinstated as Buy by Goldman Sachs
- Capital One Financial (COF)Named a fresh pick by Baird
- TeraWulf (WULF)Initiated as Buy by Bank of America with a $34 target
- Jade Biosciences (JADE)Initiated as Buy by UBS (small-cap coverage)
- CEVA, Inc. (CEVA)Initiated as Buy by Needham with a $55 target
- HawkEye 360 (HEI)Upgraded to Buy by Jefferies
- ICU Medical (ICUI)Initiated as Buy by BTIG with a $170 price target
- Twist Bioscience (TWST)Initiated as Buy by Canaccord with a $90 target
- Brookdale Senior Living (BKD)Initiated as Buy by Compass Point with a $22 target
- Paychex (PAYX)Upgraded to Buy by Citi citing bookings growth and Paycor synergies
- Coupang (CPNG)Initiated as Outperform by CLSA
- Roku (ROKU)Downgraded to Neutral by Baird
- Melius ResearchBrokerage reiterating Nvidia as Buy
- KeyBancUpgraded RKLB and FLY to Overweight
- TD CowenRaised Micron price target; provided EPS forecasts
- Morgan StanleyUpgraded Ferrari and Onto Innovation
- Goldman SachsReinstated 3M as Buy
- JPMorganInitiated Esco Technologies as Overweight
- Bank of AmericaInitiated TeraWulf as Buy
MarketMoodz Analysis
For investors, the cluster of upgrades and fresh coverage sharpens where market leadership might land this week: AI and semiconductors remain the primary risk-on lever, with Nvidia reaffirmed as a Buy and Micron drawing an aggressive price target that, if confirmed, would signal outsized expectations for memory cyclical recovery. That dynamic tends to drive sector-wide flows and volatility — long-dated options open interest and futures positioning in NVDA and MU are worth watching — while industrial and aerospace calls (Ferrari, Rocket Lab, Firefly) offer a counterbalance tied to consumer luxury and launch-capacity narratives rather than pure tech multiples.
Historically, waves of analyst revisions can move sentiment short-term but often require confirmation from company results or macro data to sustain rallies. Memory stocks have flipped quickly across cycles; an outsized Micron target ($1,500) would be unusually bullish versus historical valuation ranges and could reflect optimistic assumptions about pricing and AI-driven demand for DRAM and NAND. Similarly, upgrades of launch-service providers reflect a multi-year supply-demand gap thesis that could support higher revenue visibility, especially if SpaceX’s IPO timeline accelerates capital-market activity in the sector.
Caveats matter: many of these calls are reported from research excerpts and carry warnings about verification, anonymous sourcing, and potential conflicts. Treat the moves as indicators of analyst sentiment, not guaranteed market outcomes — confirm firm notes before adjusting allocation. Watch upcoming earnings, Micron’s near-term EPS cadence, SpaceX IPO developments, NVDA options skew and liquidity, and any official research releases from the brokerages named to separate confirmed guidance from market chatter.
Source: Original Article